Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
toxicology
Biotech
AstraZeneca stops trials of asthma drug after seeing tox signal
Pieris, which licensed the inhaled IL-4Ra inhibitor to AstraZeneca, attributed the decision to “lung findings” from a 13-week nonclinical assessment.
Nick Paul Taylor
Jun 21, 2023 9:10am
AbbVie drops midphase psoriasis drug over toxicology data
Oct 31, 2022 7:40am
Inotiv nabs MilliporeSigma BioReliance portfolio
Jul 13, 2021 7:55am
GSK taps TARA's 'heart-on-a-chip' to simulate drug responses
Aug 9, 2019 12:29pm
Covance forms dedicated biologics safety assessment unit
Mar 12, 2018 9:20am